Pediatric Crohn's Disease

DrugDrug NameDrug Description
DB00051AdalimumabA monoclonal anti-tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.
DrugDrug NameTargetType
DB00051AdalimumabTumor necrosis factortarget
DrugDrug NamePhaseStatusCount
DB00065Infliximab3Completed1
DB00563Methotrexate3Recruiting1
DB00993Azathioprine4Withdrawn1
DB00065Infliximab4Withdrawn1
DB00959Methylprednisolone4Withdrawn1